|
|
|
Insider
Information: |
Shah Nimish P |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
50,221,732 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$415,597,346 |
|
|
Total
Shares |
50,221,732 |
|
|
Total
Value |
$415,597,346 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
66
|
4
|
Stock
price went up :
|
4
|
0
|
Stock
price went down : |
62
|
4
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
Percentage
Gain/Loss : |
-54.4%
|
-384.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bellerophon Therapeutics Inc |
BLPH |
10% Owner |
2018-08-14 |
0 |
2018-09-17 |
7,386,163 |
Premium* |
|
Kalvista Pharmaceuticals Inc |
KALV |
10% Owner |
2019-03-18 |
0 |
2024-02-08 |
4,824,731 |
Premium* |
|
Constellation Pharmaceuticals Inc |
CNST |
10% Owner |
|
0 |
2019-12-13 |
4,016,873 |
Premium* |
|
Altimmune, Inc |
ALT |
10% Owner |
2020-05-26 |
0 |
2021-02-25 |
3,500,000 |
Premium* |
|
Cogent Biosciences, Inc. |
COGT |
10% Owner |
2020-08-14 |
0 |
2020-08-18 |
4,355,273 |
Premium* |
|
Tricida, Inc. |
TCDA |
10% Owner |
2022-06-02 |
0 |
2022-10-26 |
3,751,406 |
Premium* |
|
Vistagen Therapeutics Inc |
VTGN |
10% Owner |
|
0 |
2022-07-12 |
20,637,286 |
Premium* |
|
Apogee Therapeutics, Inc. |
APGE |
Director |
2023-07-13 |
0 |
2023-07-13 |
1,750,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-06-29 |
4 |
B |
$9.93 |
$164,302 |
I/I |
16,546 |
7,120,121 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-07-13 |
4 |
B |
$9.98 |
$327,903 |
I/I |
32,856 |
7,278,135 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-19 |
4 |
B |
$10.29 |
$3,272,281 |
I/I |
311,466 |
10,202,946 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-06-23 |
4 |
B |
$10.50 |
$2,100,000 |
I/I |
200,000 |
6,920,089 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-06-22 |
4 |
B |
$10.90 |
$1,557,610 |
I/I |
142,900 |
6,720,089 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-03 |
4 |
B |
$11.27 |
$3,028,655 |
I/I |
268,736 |
9,318,800 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-09-07 |
4 |
B |
$11.40 |
$5,397,433 |
I/I |
473,459 |
8,294,663 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-09-06 |
4 |
B |
$11.43 |
$1,717,049 |
I/I |
150,223 |
7,821,204 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-17 |
4 |
B |
$11.67 |
$1,987,308 |
I/I |
170,292 |
9,851,080 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-04 |
4 |
B |
$11.81 |
$2,634,811 |
I/I |
223,100 |
9,541,900 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-11 |
4 |
B |
$11.85 |
$296,250 |
I/I |
25,000 |
9,676,114 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-10 |
4 |
B |
$11.89 |
$954,933 |
I/I |
80,314 |
9,651,114 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2023-12-27 |
4 |
B |
$11.97 |
$496,923 |
I/I |
41,514 |
3,615,228 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-13 |
4 |
B |
$11.98 |
$55,995 |
I/I |
4,674 |
9,680,788 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-18 |
4 |
B |
$11.98 |
$483,992 |
I/I |
40,400 |
9,891,480 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-07 |
4 |
B |
$12.00 |
$346,800 |
I/I |
28,900 |
9,570,800 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-04 |
4 |
B |
$12.11 |
$505,762 |
I/I |
41,764 |
4,152,100 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-08-30 |
4 |
B |
$12.20 |
$610,000 |
I/I |
50,000 |
7,607,951 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-03 |
4 |
B |
$12.20 |
$214,781 |
I/I |
17,605 |
4,110,336 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-19 |
4 |
B |
$12.43 |
$310,750 |
I/I |
25,000 |
4,459,651 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-08 |
4 |
B |
$12.44 |
$860,649 |
I/I |
69,184 |
4,221,284 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-24 |
4 |
B |
$12.44 |
$257,334 |
I/I |
20,686 |
4,558,780 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2023-12-29 |
4 |
B |
$12.49 |
$75,102 |
I/I |
6,013 |
4,092,731 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2023-12-28 |
4 |
B |
$12.50 |
$5,893,625 |
I/I |
471,490 |
4,086,718 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-18 |
4 |
B |
$12.51 |
$496,397 |
I/I |
39,680 |
4,434,651 |
1.5 |
% |
|
93 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|